Introduction
Definition of isolated systolic hypertension
Isolated systolic hypertension (ISH) is a form of hypertension that occurs when the diastolic blood pressure (DBP) stays below 90 millimetres of mercury (mmHg) and the systolic blood pressure (SBP) reaches 140 (mmHg) or higher. This condition is primarily associated with ageing, as arterial stiffness increases with age, making it more common in older adults. However, younger individuals with certain medical conditions or genetic predispositions can also develop ISH.1
Importance of diagnosis and assessment
Accurate diagnosis and evaluation of ISH are crucial for several reasons. First, there is a strong correlation between ISH and cardiovascular conditions such as heart failure, coronary artery disease, and stroke. Second, precise diagnosis and evaluation aid in determining the root causes and the extent of organ damage, hence guiding suitable treatment plans. Prompt intervention can help prevent complications and enhance long-term outcomes.1
Diagnosis of isolated systolic hypertension
Blood pressure measurement techniques
To diagnose ISH, accurate blood pressure measurement is essential. It is advised to use a properly calibrated sphygmomanometer, position the patient appropriately, and take repeated readings at various intervals to account for fluctuations. Additionally,, home blood pressure monitoring (HBPM) and ambulatory blood pressure monitoring (ABPM) may also be used to confirm the diagnosis.2
Diagnostic criteria
Repeated readings of increased SBP (≥140 mm Hg) and normal DBP (<90 mm Hg), obtained at separate times, provide the basis for the diagnosis of ISH. Standard measuring methods should be used to confirm the diagnosis and rule out any secondary causes of hypertension. Furthermore, to evaluate for underlying disorders and target organ damage, laboratory testing and imaging exams may be carried out.3
Evaluation of target organ damage
Assessing target organ damage is essential in individuals with ISH to determine the extent of cardiovascular risk and guide treatment decisions. Commonly evaluated organs include the heart, brain, kidneys, and blood vessels. Diagnostic tests such as electrocardiography (ECG), echocardiography, carotid ultrasound, and renal function tests may be utilised to assess for hypertensive organ damage.4
This thorough evaluation helps clinicians understand the severity of hypertension and tailor management strategies accordingly, aiming to reduce the risk of cardiovascular events and improve the overall prognosis.
Assessment of isolated systolic hypertension
Medical history taking
Taking a comprehensive medical history is crucial in assessing isolated systolic hypertension. Important aspects to inquire about include the duration and severity of hypertension, previous diagnoses, medication history, family history of cardiovascular diseases, lifestyle factors such as diet and exercise, and any symptoms suggestive of target organ damage. Identifying potential secondary causes of hypertension is essential during this process.5
Physical examination
A thorough physical examination complements the medical history in assessing isolated systolic hypertension. Examination findings may include elevated blood pressure readings, signs of target organ damage such as retinal changes, cardiac murmurs, evidence of peripheral artery disease, and signs of end-organ damage such as heart failure or chronic kidney disease. Additionally, assessing for signs of secondary causes of hypertension, such as thyroid enlargement or abdominal bruits, is essential.3
Laboratory tests
Laboratory tests play a vital role in evaluating isolated systolic hypertension and identifying underlying causes and target organ damage. Commonly ordered tests include a complete blood count (CBC), electrolyte panel, renal function tests (creatinine and estimated glomerular filtration rate), lipid profile, fasting glucose levels, and urinalysis. Additional tests may be indicated based on the clinical presentation and suspected aetiology of hypertension.2
Diagnostic imaging
Diagnostic imaging studies help assess target organ damage and identify potential secondary causes of hypertension. Imaging modalities commonly used in the evaluation of isolated systolic hypertension include electrocardiography (ECG) to assess for left ventricular hypertrophy or ischemia, echocardiography to evaluate cardiac structure and function, carotid ultrasound to assess for carotid artery disease, and renal imaging (such as ultrasound or CT scan) to evaluate for renal artery stenosis or other renal abnormalities.2
Differential diagnosis
Secondary causes of hypertension
Isolated systolic hypertension can be secondary to various underlying conditions, including renal artery stenosis, hyperthyroidism, Cushing's syndrome, pheochromocytoma, coarctation of the aorta, and obstructive sleep apnea, among others. A thorough evaluation, including medical history, physical examination, and appropriate laboratory and imaging tests, is necessary to identify these secondary causes and guide management.6
Differentiating isolated systolic hypertension from other conditions
Isolated systolic hypertension must be differentiated from other conditions that may present with similar blood pressure patterns. These include white coat hypertension, masked hypertension, and pseudohypertension. Ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) may be useful in distinguishing between these conditions and confirming the diagnosis of isolated systolic hypertension.3
Management and Treatment Options
Lifestyle modifications
Lifestyle modifications play a fundamental role in the management of isolated systolic hypertension and can effectively lower blood pressure levels. Recommendations include adopting a heart-healthy diet rich in fruits, vegetables, whole grains, and lean proteins while limiting sodium intake. Regular physical activity, maintaining a healthy weight, limiting alcohol consumption, and managing stress through relaxation techniques or mindfulness can also help reduce blood pressure.7
Pharmacological interventions
Pharmacological interventions are often necessary to achieve target blood pressure levels in individuals with isolated systolic hypertension, particularly when lifestyle modifications alone are insufficient. Antihypertensive medications commonly used include thiazide diuretics, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and beta-blockers. Treatment regimens are individualised based on patient characteristics, comorbidities, and medication tolerability.8
Follow-up and monitoring
Regular follow-up visits are essential to monitor blood pressure control, assess treatment efficacy, and adjust management strategies as needed. During follow-up appointments, blood pressure measurements should be obtained using standardised techniques, and patients should be evaluated for medication adherence, lifestyle modifications, and any adverse effects of treatment. Close monitoring allows healthcare providers to optimise therapy and reduce the risk of cardiovascular complications.9
Prognosis and complications
Impact on cardiovascular health
Isolated systolic hypertension significantly increases the risk of cardiovascular events such as stroke, myocardial infarction, heart failure, and peripheral vascular disease. Elevated systolic blood pressure exerts continuous pressure on arterial walls, leading to arterial stiffness, endothelial dysfunction, and target organ damage. Timely diagnosis and effective management are crucial in reducing cardiovascular morbidity and mortality associated with this condition.7
Long-term implications
Untreated or poorly controlled isolated systolic hypertension can have serious long-term implications for overall health and quality of life. Chronic hypertension contributes to the development and progression of atherosclerosis, renal dysfunction, cognitive decline, and other cardiovascular complications over time. However, with appropriate management, including lifestyle modifications and pharmacological interventions, the long-term prognosis can be significantly improved, reducing the risk of complications and improving the quality of life for affected individuals.7
FAQs
Can lifestyle modifications alone manage isolated systolic hypertension?
While lifestyle modifications such as dietary changes, exercise, and stress reduction can help lower blood pressure, some individuals may require pharmacological interventions for optimal management.7
Isolated systolic hypertension only affects older adults?
While it is more prevalent in older adults due to age-related changes in blood vessels, it can also occur in younger individuals, especially those with underlying health conditions or genetic predispositions.10
What are the common complications of isolated systolic hypertension?
Complications may include an increased risk of stroke, heart attack, heart failure, kidney disease, and other cardiovascular conditions if left untreated or poorly managed. Early diagnosis and appropriate management are essential in reducing these risks.11
Can isolated systolic hypertension be cured, or is it a lifelong condition?
Isolated systolic hypertension is typically a chronic condition that requires ongoing management to control blood pressure and reduce cardiovascular risk. While lifestyle modifications and medications can effectively lower blood pressure levels, they may not completely cure the underlying arterial stiffness or hypertension. However, with consistent treatment and adherence to healthy habits, individuals with isolated systolic hypertension can effectively manage their condition and minimise associated risks.
Summary
Isolated systolic hypertension, characterised by elevated systolic blood pressure and normal diastolic pressure, necessitates accurate diagnosis and assessment to mitigate cardiovascular risks effectively. Through thorough medical history taking, physical examination, and diagnostic tests, healthcare professionals can identify underlying causes and assess target organ damage, guiding tailored management strategies. Early detection and intervention play pivotal roles in mitigating complications and improving long-term outcomes for individuals with isolated systolic hypertension.
References
- Brunström M, Carlberg B, Kjeldsen SE. Effect of antihypertensive treatment in isolated systolic hypertension (ISH) - systematic review and meta-analysis of randomised controlled trials. Blood Press. 2023 Dec;32(1):2226757. Available from: https://pubmed.ncbi.nlm.nih.gov/37395100/
- Li FR, He Y, Yang HL, Liu HM, Zhou R, Chen GC, et al. Isolated systolic and diastolic hypertension by the 2017 American College of Cardiology/American Heart Association guidelines and risk of cardiovascular disease: a large prospective cohort study. J Hypertens. 2021 Aug 1;39(8):1594–601. Available from: https://pubmed.ncbi.nlm.nih.gov/33560057/
- Janiec S, Stępień K, Skorek P, Kolodziejski M, Stępień A, Olszanecka A, et al. Isolated systolic hypertension — evaluation of the scale of the problem among medical students — pilot study. Arter Hypertens [Internet]. 2017;21:132–9. Available from: https://api.semanticscholar.org/CorpusID:56067331
- Floria M, Tănase DM. Subclinical target organ damage as risk stratification parameter in hypertensive patients. J Clin Ultrasound JCU. 2022 Jul;50(6):769–71. Available from: https://pubmed.ncbi.nlm.nih.gov/35834667/
- Lee H, Yano Y, Cho SMJ, Park JH, Park S, Lloyd-Jones DM, et al. Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults. Circulation. 2020 Jun 2;141(22):1778–86. Available from: https://pubmed.ncbi.nlm.nih.gov/32479205/#:~:text=Conclusions%3A%20Among%20young%20adults%2C%20stage,risk%20of%20stage%201%20SDH.
- Prisant LM, Gujral JS, Mulloy AL. Hyperthyroidism: a secondary cause of isolated systolic hypertension. J Clin Hypertens Greenwich Conn. 2006 Aug;8(8):596–9. Available from: https://pubmed.ncbi.nlm.nih.gov/16896276/
- Wong J, Wong S. Evidence-based care for the elderly with isolated systolic hypertension. Nurs Health Sci. 2005 Mar;7(1):67–75. Available from: https://pubmed.ncbi.nlm.nih.gov/15670008/
- Noone C, Leahy J, Morrissey EC, Newell J, Newell M, Dwyer CP, et al. Comparative efficacy of exercise and anti-hypertensive pharmacological interventions in reducing blood pressure in people with hypertension: A network meta-analysis. Eur J Prev Cardiol. 2020 Feb;27(3):247–55. Available from: https://pubmed.ncbi.nlm.nih.gov/31615283/#:~:text=The%20point%20estimates%20suggested%20that,than%20did%20the%20exercise%20interventions.
- Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999 Aug 11;282(6):539–46. Available from: https://pubmed.ncbi.nlm.nih.gov/10450715/
- Martins D, Nelson K, Pan D, Tareen N, Norris K. The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III. J Gend-Specif Med JGSM Off J Partners Womens Health Columbia. 2001;4(3):10–3, 20. Available from: https://pubmed.ncbi.nlm.nih.gov/11605350/
- Felek D, Çi̇fci̇ A. Approach to hypertension in the geriatric population. J Cardiol Amp Cardiovasc Surg [Internet]. 2023; Available from: https://api.semanticscholar.org/CorpusID:264065870